Can I Take Vitamin B12 With Ozempic?

The Short Answer: No Interaction, But There Is a Real Concern

Vitamin B12 and Ozempic do not interact. Semaglutide works by binding glucagon-like peptide-1 receptors; B12 is absorbed through an entirely separate pathway involving intrinsic factor in the small intestine. These two mechanisms do not overlap, and no published pharmacokinetic study has shown semaglutide altering B12 absorption, distribution, or excretion.

The concern worth understanding is indirect. Many women prescribed Ozempic for type 2 diabetes are also on metformin, which does deplete B12 through a different and well-characterized mechanism. If that describes you, B12 supplementation is something your prescriber should actively address, not just tolerate.

Why This Matters More for Women

Women are diagnosed with type 2 diabetes at slightly lower body-mass indices than men, and women with PCOS are prescribed metformin at high rates, often for years before a diabetes diagnosis is confirmed. PCOS affects 8 to 13% of women of reproductive age, and metformin remains a first-line insulin-sensitizing agent for this condition. That means a substantial number of women reading this article may be on both metformin and semaglutide simultaneously, which changes the B12 conversation considerably.

How Metformin Depletes B12 (and Why Semaglutide Gets Caught Up in It)

Metformin reduces B12 absorption by blocking calcium-dependent membrane action of the ileal cubilin receptor complex, which is required for the intrinsic-factor-B12 complex to be taken up into enterocytes. A 2006 cross-sectional analysis found that metformin use was associated with B12 deficiency in up to 30% of long-term users, and the UKPDS and DPP follow-on data have confirmed the association.

Semaglutide does none of this. It slows gastric emptying, which theoretically could reduce the speed at which B12 reaches the ileum, but this effect is modest and has not been shown in any clinical trial to cause clinically meaningful B12 malabsorption on its own. There is no published evidence that semaglutide at doses of 0.5 mg, 1.0 mg, or 2.0 mg alters serum B12 levels independently of metformin.

What Gastric Emptying Slowing Actually Does

Semaglutide significantly delays gastric emptying, a property measured in the SUSTAIN-6 trial supporting cardiovascular outcomes for the drug. This slowing affects oral medications with narrow absorption windows more than it affects vitamins taken as supplements, and B12 does not have a narrow absorption window in the pharmacological sense. Oral B12 supplements at doses of 500 mcg or higher are absorbed partly by passive diffusion across the gut wall, which does not depend on intrinsic factor at all. That passive pathway is not meaningfully affected by delayed gastric transit.

The Triple-Therapy Scenario: Metformin + Semaglutide + PPI

One underappreciated scenario for women is the combination of metformin, semaglutide, and a proton-pump inhibitor. Proton-pump inhibitors reduce gastric acid, which impairs the release of food-bound B12 from protein. Long-term PPI use is independently associated with B12 deficiency, and women on Ozempic for gastrointestinal side-effect management sometimes add a PPI. Each drug alone poses limited risk; all three together substantially raise the chance of subclinical depletion.

B12 Deficiency: How It Looks in Women at Each Life Stage

B12 deficiency is insidious because early symptoms mimic many conditions that women are already navigating.

Reproductive Years (Ages 18 to 40)

Fatigue, irregular periods, and mood changes are common enough in this group that B12 deficiency is routinely missed. Serum B12 below 200 pg/mL is associated with macrocytic anemia and peripheral neuropathy, but symptoms can appear at low-normal levels. Women taking oral contraceptives also have modestly lower B12 levels at baseline, which is not widely known. If you are in your reproductive years, on metformin for PCOS, and starting semaglutide for metabolic reasons, your prescriber should check a baseline B12 before assuming the fatigue you feel is only from calorie restriction.

Trying to Conceive and Early Pregnancy

B12 is essential for neural tube development alongside folate. Adequate B12 status before conception is recommended by ACOG to reduce the risk of neural tube defects. Women planning pregnancy should have their B12 checked and, if levels are suboptimal, should supplement before stopping contraception.

Ozempic is contraindicated in pregnancy. See the dedicated section below.

Perimenopause (Ages 40 to 55)

This is the life stage where B12 deficiency becomes easiest to overlook. Perimenopause brings its own fatigue, brain fog, tingling extremities, and mood instability, all of which overlap with B12-deficiency symptoms. Atrophic gastritis, which reduces intrinsic factor secretion, becomes more common after age 50 and can reduce B12 absorption from food regardless of metformin use. The prevalence of atrophic gastritis is estimated at 27 to 37% in adults over 60, and it begins developing silently in the perimenopause window. Women in this group should treat a serum B12 below 300 pg/mL as clinically meaningful, even if it sits within the laboratory's reference range.

Postmenopause

Absorption efficiency falls further after menopause. Women who have been on metformin for years, who may now also be taking semaglutide (Ozempic or Wegovy) for metabolic or cardiovascular risk reduction, and who have age-related reductions in intrinsic factor are the highest-risk group. Oral supplementation at 1,000 mcg daily, or an intramuscular B12 injection every 1 to 3 months if absorption is severely compromised, is a reasonable approach. Your clinician should confirm which form is appropriate based on your serum level.

Is There Any Direct Pharmacokinetic Interaction?

No. The FDA label for Ozempic does not list vitamin B12 as a drug interaction. The prescribing information for semaglutide injection addresses drug interactions only in terms of oral medications affected by gastric-emptying delay, and vitamins are not included. There is no published pharmacokinetic study in humans showing semaglutide alters B12 serum levels by any direct mechanism.

A useful framework for thinking about this:

Direct pharmacokinetic interaction: Does semaglutide change how B12 is absorbed, distributed, metabolized, or excreted? No published evidence says yes.

Indirect pharmacodynamic interaction: Does semaglutide, through its mechanism, create conditions that worsen B12 status? Gastric emptying slowing is plausible in theory but not clinically demonstrated as a cause of B12 deficiency.

Co-medication interaction: Does the medication most often prescribed alongside semaglutide in your population cause B12 depletion? Yes. Metformin does this clearly.

The third category is why women on both medications need monitoring, not because of Ozempic, but because of the company it keeps.

Recommended Supplementation: Form, Dose, and Timing

Which Form of B12?

Two forms dominate the supplement market: cyanocobalamin and methylcobalamin. Cyanocobalamin is the form best studied in clinical trials and is used in the DPP long-term follow-up data examining metformin and B12. Methylcobalamin is the active cofactor form and is preferred by some clinicians for individuals with MTHFR variants or those who feel subjectively better on it, though head-to-head data on clinical outcomes are limited.

For most women, cyanocobalamin at 500 to 1,000 mcg orally per day is an appropriate starting place if your prescriber confirms supplementation is warranted. Women with confirmed malabsorption, severe atrophic gastritis, or neurological symptoms may need intramuscular injections.

Does Timing Matter?

You do not need to separate B12 from your Ozempic injection. Ozempic is given as a subcutaneous injection once weekly; B12 is taken orally daily. They do not share a route of administration and there is no interaction window to manage.

If you take metformin with your B12, taking B12 with a meal that includes calcium may partially counteract metformin's blockade of the ileal receptor, a strategy mentioned in a randomized trial by Bauman et al. Published in Diabetes Care. This is a modest effect, not a cure for metformin-related depletion, but worth knowing.

What Dose Does the Evidence Support?

The Diabetes Prevention Program Outcomes Study (DPPOS) examined metformin's effect on B12 over 13 years and found that participants on metformin had a 13% greater risk of B12 deficiency than placebo-treated participants. The study did not mandate supplementation, which is part of why the deficiency rates were notable. Standard guidance from that data and subsequent commentary supports monitoring serum B12 annually in metformin users and treating deficiency with supplementation at 500 to 1,000 mcg daily.

For women not on metformin who are taking Ozempic alone, there is no evidence base supporting routine B12 supplementation beyond what is already in a standard prenatal or multivitamin if dietary intake is adequate.

Monitoring: What to Ask Your Prescriber to Check

Ask for a serum B12 level at your next visit if you are on metformin plus semaglutide and have never had one checked. The test is inexpensive and widely available. Some clinicians also check methylmalonic acid (MMA) and homocysteine, which rise before serum B12 falls below the standard deficiency threshold and can detect functional depletion earlier. This is worth requesting if you have neurological symptoms (tingling hands or feet, balance issues, memory changes) even with a "normal" B12 result.

The American Diabetes Association Standards of Care recommend periodic measurement of B12 in patients on long-term metformin. "Periodic" is not defined precisely, but annual testing is widely accepted practice and is what the DPPOS authors recommended.

"Long-term metformin therapy is associated with vitamin B12 deficiency. Periodic measurement of vitamin B12 levels should be considered in metformin-treated patients, especially in those with peripheral neuropathy or anemia," state the 2024 ADA Standards of Care.

Pregnancy, Lactation, and Contraception

This section is required for any article covering Ozempic, and the information here is not optional reading.

Ozempic Is Contraindicated in Pregnancy

Semaglutide is a pregnancy category X equivalent under modern labeling. The FDA label for semaglutide states that Ozempic should be discontinued at least 2 months before a planned pregnancy. Animal studies showed fetal harm at doses relevant to human exposure; human data are inadequate to establish safety, and the drug's long half-life of approximately one week means it takes several weeks to clear after the last dose. The 2-month washout window is intended to allow full elimination.

If you are using Ozempic and are of reproductive age, you must use reliable contraception. This is non-negotiable while on the drug, and your prescriber should confirm your contraceptive plan at every visit.

Oral Contraceptives and Semaglutide

Semaglutide's gastric-emptying delay can theoretically reduce peak plasma concentrations of oral contraceptives taken around the same time as a meal. A pharmacokinetic substudy published with the SUSTAIN program data found no clinically meaningful interaction, but the FDA label advises that oral medications with time-sensitive absorption should be taken with caution. Taking your oral contraceptive at a consistent time, not necessarily separated from semaglutide, is the standard guidance. If you are using oral contraceptives specifically for contraception rather than cycle management, discuss with your prescriber whether a non-oral method might be more reliable while you are on Ozempic.

Vitamin B12 in Pregnancy

B12 is safe and necessary in pregnancy. Deficiency in early pregnancy is associated with neural tube defects and poor fetal neurodevelopment. If you are stopping Ozempic to conceive, continuing or starting a prenatal vitamin with at least 2.6 mcg of B12 (the RDA in pregnancy) is appropriate. Women who have been on long-term metformin before stopping it for pregnancy should have B12 checked early in the first trimester regardless, because stores may already be depleted.

Lactation

Vitamin B12 passes into breast milk and is essential for infant neurological development. There is no concern about taking B12 while breastfeeding. Semaglutide, by contrast, is not recommended during lactation. Human data on breast milk transfer are absent, and the conservative approach is to avoid it until more data exist. Breastfeeding women managing type 2 diabetes or PCOS-related insulin resistance have other medication options; discuss these with your prescriber.

Who This Is Right For (and Who Needs Extra Attention)

Most Likely to Benefit From B12 Monitoring While on Ozempic

• Women taking metformin alongside semaglutide (any dose)
• Women with PCOS who have been on metformin for more than 12 months
• Perimenopausal or postmenopausal women (reduced intrinsic factor capacity)
• Women on long-term PPI therapy (omeprazole, pantoprazole, lansoprazole)
• Women with a history of bariatric surgery (impaired intrinsic factor production)
• Vegetarians and vegans (lower dietary B12 at baseline)
• Women with peripheral neuropathy symptoms at any age

Women for Whom Routine B12 Supplementation May Not Be Necessary

• Women on Ozempic alone, not on metformin, with adequate dietary B12 intake and no absorption-impairing conditions
• Women already taking a prenatal or multivitamin containing B12

Even in the second group, checking a serum B12 once costs little and provides a useful baseline. It is not a high-stakes test.

The Evidence Gap: What We Do Not Know Yet

Women have been historically under-represented in GLP-1 receptor agonist trials. The SUSTAIN program enrolled approximately 54 to 57% male participants across its phases, meaning that sex-specific subgroup analyses for outcomes like micronutrient status are either underpowered or absent. No published trial has prospectively studied B12 levels specifically in women on semaglutide with and without metformin, stratified by menopausal status or PCOS diagnosis.

What is known comes from:

1. Metformin-B12 depletion data (well-established, decades of evidence)
2. GLP-1 pharmacokinetics showing no direct B12 pathway involvement (mechanistically reassuring)
3. Extrapolation from older GLP-1 agents (exenatide, liraglutide) in which no B12 interaction was found

The honest conclusion is that semaglutide almost certainly does not deplete B12 directly, but the populations most commonly prescribed it do face real B12 depletion risk from co-medications and life-stage factors. Monitoring fills that gap while better-designed, women-specific trials are conducted.

Dr. Maya Okafor, OB-GYN and WomanRx medical reviewer, notes: "In my practice, I routinely check B12 in any woman who has been on metformin for more than a year before we add semaglutide. The combination of metformin-related depletion, perimenopausal gastric changes, and GLP-1-related appetite suppression reducing dietary variety creates a perfect storm for subclinical B12 insufficiency that gets blamed on burnout or hormones."

A Quick Practical Summary

You can take vitamin B12 with Ozempic. No timing separation is needed. No dose adjustment is required for either. The decision to supplement should be driven by your serum B12 level, your metformin status, your life stage, and your dietary intake. If you have been on metformin for more than 12 months and have never had a B12 level drawn, that test should happen at your next visit whether or not you are on Ozempic.

Ask your prescriber specifically: "Given that I'm on metformin and semaglutide, should we check my B12 and methylmalonic acid levels?" If the answer is not a clear yes or a clear explanation of why not, advocate for the test. Subclinical B12 deficiency causing peripheral neuropathy is preventable, and prevention starts with measurement.